pGEX/PD-L1 WT Citations (2)

Originally described in: Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity.
Li CW, Lim SO, Xia W, Lee HH, Chan LC, Kuo CW, Khoo KH, Chang SS, Cha JH, Kim T, Hsu JL, Wu Y, Hsu JM, Yamaguchi H, Ding Q, Wang Y, Yao J, Lee CC, Wu HJ, Sahin AA, Allison JP, Yu D, Hortobagyi GN, Hung MC Nat Commun. 2016 Aug 30;7:12632. doi: 10.1038/ncomms12632. PubMed Journal

---

Articles Citing pGEX/PD-L1 WT

Articles
Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation. Xu X, Xie T, Zhou M, Sun Y, Wang F, Tian Y, Chen Z, Xie Y, Wu R, Cen X, Zhou J, Hou T, Zhang L, Huang C, Zhao Q, Wang D, Xia H. Nat Commun. 2024 May 18;15(1):4237. doi: 10.1038/s41467-024-48597-3. PubMed
68Ga-NK224 PET/CT for Non-Invasive Evaluation of PD-L1 Expression and Inter-Tumor Heterogeneity: A Translational Exploratory Study. Zhao L, Pang Y, Ding Y, Chen J, Fang J, Yu L, Ruan D, Dai Y, Zhou H, Fu H, Guo W, Sun L, Wu H, Zhong S, Lin Q, Chen H. Clin Cancer Res. 2025 May 9. doi: 10.1158/1078-0432.CCR-25-0160. PubMed

If you have published an article using this material, please email us at to have your article added to this page.